000 01350 a2200361 4500
005 20250516033950.0
264 0 _c20110927
008 201109s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/j.1365-2036.2011.04667.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVeerappan, S G
245 0 0 _aReview article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cJun 2011
300 _a1261-72 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Cortex Hormones
_xadverse effects
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aFemale
650 0 4 _aFractures, Bone
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xcomplications
650 0 4 _aInfliximab
650 0 4 _aMale
650 0 4 _aOsteoporosis
_xchemically induced
650 0 4 _aTumor Necrosis Factor-alpha
_xpharmacology
700 1 _aO'Morain, C A
700 1 _aDaly, J S
700 1 _aRyan, B M
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 33
_gno. 12
_gp. 1261-72
856 4 0 _uhttps://doi.org/10.1111/j.1365-2036.2011.04667.x
_zAvailable from publisher's website
999 _c20786145
_d20786145